INVENTVACC BIOLOGICALS INC.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.inventvacc.com
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine
Phase 1
Active, not recruiting
- Conditions
- Invasive Haemophilus Influenzae DiseaseHaemophilus Influenzae Meningitis
- Interventions
- Biological: Haemophilus influenzae type a (Hia) glycoconjugate vaccine
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- InventVacc Biologicals Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06465420
- Locations
- 🇨🇦
Canadian Center for Vaccinology (CCfV), Halifax, Nova Scotia, Canada
🇨🇦McGill University Health Centre (MUHC) Vaccine Study Centre, Montreal, Quebec, Canada
News
No news found